Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 May;12(3):614-621.
doi: 10.1177/1932296817740592. Epub 2017 Nov 24.

Time Savings Using a Standardized Glucose Reporting System and Ambulatory Glucose Profile

Deborah M Mullen  1 , Richard Bergenstal  1 , Amy Criego  2 , Kathleen Cecilia Arnold  3 , Robin Goland  4 , Sara Richter  5
Affiliations
Multicenter Study

Time Savings Using a Standardized Glucose Reporting System and Ambulatory Glucose Profile

Deborah M Mullen et al. J Diabetes Sci Technol. 2018 May.

Abstract

Background: Diabetes care is predominately done at home by the patient. When clinics do not have a reliable, easy process for obtaining this patient data, clinical decisions must be made with incomplete verbal recall reports. Unused or inaccessible glucose data represent a large information gap affecting clinical decision making. This study's purpose was to design an optimized glucose device download system with a standardized report and to evaluate its efficiency.

Methods: Observations and evaluations of glucose data retrieval occurred at two clinics; an additional clinic utilized the optimized process doing only post process timings. Patients/families and clinicians were surveyed about their experiences with the system and the standardized report (AGP). The study was approved by all the sites' IRBs.

Results: Optimized systems saved staff at least 3 min per patient. Standardized AGP reports and an optimized data system made the work flow of glucose data easier to complete. The AGP report was preferred by patients, families, and clinicians.

Conclusions: An optimized system takes advantage of patient lobby downtime to download glucose devices and ensures that diabetes clinical decisions are made utilizing all available data. Staff and patients liked the software lobby system and found it a valuable time-saving tool.

Keywords: AGP; diabetes care; standardized systems; time savings.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: DMM’s nonprofit employer has received research grants from Abbott Diabetes Care and Dexcom for which there was no personal compensation. RB’s nonprofit employer has received consultant payments on his behalf from Abbott Diabetes Care, Amylin, Animas, Bayer, Boehringer Ingelheim, Calibra, Eli Lilly, the Helmsley Trust, Hygieia, Johnson & Johnson, Medtronic, Novo Nordisk, Roche, Sanofi, Takeda, and Tandem with no personal compensation; research grants from Abbott Diabetes Care, Animas, Bayer, Becton Dickinson, Boehringer Ingelheim, Bigfoot, Calibra, DexCom, Eli Lilly, Helmsley Trust, Hygieia, Johnson & Johnson, Medtronic, Merck, NIH, Novo Nordisk, Roche, Sanofi, Takeda, and Tandem with no personal compensation. RB’s employer receives royalties from the Betty Crocker Diabetes Cookbook, and RB holds stock in Merck. AC’s nonprofit employer has received research grants from Abbott Diabetes Care, Animas, Bayer, Becton Dickinson, Boehringer Ingelheim, Bigfoot, Calibra, DexCom, Eli Lilly, Helmsley Trust, Hygieia, Johnson & Johnson, Medtronic, Merck, NIH, Novo Nordisk, Roche, Sanofi, Takeda, and Tandem with no personal compensation. KCA is a speaker for Sanofi, NovoNordisk, AstraZeneca, and Valeritas and does research for Type 1 DM exchange, Medtronic, Roche. For the remaining authors none were declared.

Figures

Figure 1.
Figure 1.
CaptūrAGP report—continuous glucose monitoring (CGM).
Figure 2.
Figure 2.
CaptūrAGP report—self-monitoring blood glucose (SMBG).
See this image and copyright information in PMC

References

    1. Bergenstal RM. Glycemic variability and diabetes complications: does it matter? Simply put, there are better glycemic markers! Diabetes Care. 2015;38(8):1615-1621. - PubMed
    1. Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2011;12(1):11-17. - PubMed
    1. Renard E. Monitoring glycemic control: the importance of self-monitoring of blood glucose. Am J Med. 2005;118(9):12-19. - PubMed
    1. McElwee-Malloy M. The right meter for you. Diabetes Forecast. 2016;69(2):50-63. - PubMed
    1. Evans M, Cranston I, Bailey CJ. Ambulatory glucose profile (AGP): utility in UK clinical practice. Br J Diabetes. 2017;17(1):26-33.

Publication types

LinkOut - more resources